Source: Annual Congress 2009 - Lung cancer biology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. Vrioni, T. Theodoropoulos (Athens, Greece; Tampa, United States Of America). Lung cancer and metabolism: a role for glucagon?. Eur Respir J 2009; 34: Suppl. 53, 286

Member's Comments

No comment yet.

Related content which might interest you: Lung cancer: only tobacco-smoking? Source: Annual Congress 2004 - Occupational Grand Round, an interactive session Year: 2004 Investigate which PKC isoform play an important role in human lung cancer cells against TRAIL-induced apoptosis Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Lung ageing and COPD: is there a role for ageing in abnormal tissue repair? Source: Eur Respir Rev, 26 (146) 170073; 10.1183/16000617.0073-2017 Year: 2017 Role of insulin and IGF-1 receptors in bronchial epithelial cancer cells Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 The role of HIF-1 pathway in non-small-cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Angiogenesis in IPF and lung Cancer: a common pathway? Source: Research Seminar 2015 Year: 2015 The role of pre-receptor glucocorticoid metabolism in regulating the severity and persistence of murine lung injury Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Deciphering the link between COPD and lung cancer: Cigarette smoke-induced immunosuppression at the crossroads between cancer immune surveillance and escape Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Lung cancer: oncogenesis and prevention Source: Eur Respir Mon; 2009: 44: 1–14 Year: 2009 Lung cancer or cancer of the lung: a view from the bridge Source: Virtual Congress 2020 – Lung cancer or cancer of the lung Year: 2020 Possible role of nuclear receptor nr4a1 in hypoxia-induced cisplatin resistance Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Metabolic modification as a potential therapeutics approach in lung cancer Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Epigenetic alterations in the circulating DNA from blood of patients with COPD and lung cancer Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment? Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015 Accelerated lung function decline increases the risk of lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Regulatory T, B cells and inflammation: Do they play an important role in lung cancer? Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 A requirement for IKKa in lung adenocarcinoma Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Metabolic signatures associated with lung cancer using serum samples. Influence of hemolysis Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014